Expression of the human β3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation

Journal of Cellular Physiology

Volumn 214, Issue 2, 2008, Pages 306-315

  Xi, Gang ^a   Maile, Laura A ^a   Yoo, Sung Eun ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; SOMATOMEDIN C; VITRONECTIN; IMMUNOGLOBULIN RECEPTOR; LIGAND; PTPNS1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; AMINO ACID SEQUENCE; ANIMAL; AORTA; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

SUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; AORTA; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; GRB2 ADAPTOR PROTEIN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN BETA3; LIGANDS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TYROSINE; VITRONECTIN;

EID: 37349093725     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21196     Document Type: Article

References (58)

1. Biedi C, Panetta D, Segat D, Cordera R, Maggi D. 2003. Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae. Endocrinology 144:5497-5503.
2. Boney CM, Gruppuso PA, Faris RA, Frackelton AR, Jr. 2000. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-LI preadipocytes. Mol Endocrinol 14:80S-813.
3. Calkin AC, Allen TJ. 2006. Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention. Am J Cardiovasc Drugs 6:15-40.
4. Campbell M, Allen WE, Silversides JA, Trimble ER. 2003. Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation pf the platelet-derived growth factor-beta receptor potentiates vascu ar smooth muscle cell Chemotaxis. Diabetes S2:519-526.
5. Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, Villa BR, Novack DV, Parks WC, Abendschein DR. 2004. Beta3-integrin mediates smooth muscle cell accumulation n neointima after carotid ligation in mice. Circulation 109:1564-1S69.
6. Chow JC, Condorelli G, Smith RJ. 1998. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-I pathway. J Biol Chem 273:4672-4680.
7. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Lamaziere JM, Bonnet J. 1998. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 18:168-176.
8. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS. 1991. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266:1S917-1S923.
9. Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T, Kasuga M. 1996. A novel membrane glycoprotein, SHPS-I, that binds the SH2-dorrain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 16:6887-6899.
10. Galvin CD, Hardiman O, Nolan CM. 2003. IGF-I receptor mediates differentiation of primary cultures of mouse skeletal myoblasts. Mol Cell Endocrinol 200:19-29.
11. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696.
12. Gockerman A, Prevette T, Jones JI, Clemmons DR. 1995. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136:4168-4173.
13. Goldberg IJ, Dansky HM. 2006. Diabetic vascular disease: An experimental objective. Arterioscler Thromb Vasc Biol 26:1693-1701.
14. Gotoh N, Toyoda M, Shibuya M. 1997. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol Cell Biol 17:1824-1831.
15. Gresham HD, Dale BM, Potter JW, Chang PW, Vines CM, Lowell CA, Lagenaur CF, Willman CL. 2000. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. J Exp Med 191:515-528.
16. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N, Perrey S, lizuka Y, Tamura Y, Amemiya-Kudo M, Yoshikawa T, Okazaki H, Ohashi K, Harada K, Matsuzaka T, Sone H, Gotoda T, Nagai R, lshibashi S, Yamada N. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276:37402-37408.
17. Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. 1988. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 107:307-319.
18. Ishihara H, Sasaoka T, Wada T, lshiki M, Haruta T, Usui I, Iwata M, Takano A, Uno T, Ueno E, Kobayashi M. 1998. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat I fibroblasts expressing insulin receptors. Biochem Biophys Res Commun 252:139-144.
19. Jones JI, Prevette T, Gockerman A, Clemmons DR. 1996. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487.
20. Kako Y, Huang LS, Yang J, Katopodis T, Ramakrishnan R, Goldberg IJ. 1999. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis. J Lipid Res 40:2185-2194.
21. Keren P, George J, Shaish A, Levkovitz H, Janakovic Z, Afek A, Goldberg I, Kopolovic J, Keren G, Harats D. 2000. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49:1064-1069.
22. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181-186.
23. Kim B, Cheng HL, Margolis B, Feldman EL. 1998. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J Biol Chem 273:34543-34550.
24. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N. 2000. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 105:451-458.
25. Lieskovska J, Ling Y, Badley-Clarke J, Clemmons DR. 2006. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J Biol Chem 281:25041-25053.
26. Ling Y, Maile LA, Clemmons DR. 2003. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor. Mol Endocrinol 17:1824-1833.
27. Ling Y, Maile LA, Lieskovska J, Badley-Clarke J, Clemmons DR. 2005. Role of SHPS-I in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Mol Biol Cell 16:3353-3364.
28. Maile LA, Clemmons DR. 2002. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology 143:4259-4264.
29. Maile LA, Clemmons DR. 2003. Integrin-associated protein binding domain of thrombospondin-I enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ Res 93:925-931.
30. Maile LA, Badley-Clarke J, Clemmons DR. 2001. Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling. J Cell Sci 114:1417-1425.
31. Maile LA, Badley-Clarke J, Clemmons DR. 2003. The association between integrin-associated protein and SHPS-I regulates insulin-like growth factor-J receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14:3519-3528.
32. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Ling Y, Clemmons DR. 2006a. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol 20:881-892.
33. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR. 2006b. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTCI84 sequence of the beta3-subunit of alphaVbeta3. Mol Endocrinol 20:405-413.
34. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR. 2007. Hyperglycemia alters the responsiveness of smooth muscle cells to Insulin-Like Growth Factor-I. Endocrinology 148:243S-2443.
35. Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD. 1999. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19:1223-1230.
36. Nam TJ, Busby WH, Jr, Rees C, Clemmons DR. 2000. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology 141:1100-1106.
37. Oh ES, Gu H, Saxton TM, Timms JF, Hausdorff S, Frevert EU, Kahn BB, Pawson T, Neel BG, Thomas SM. 1999. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol Cell Biol 19:3205-3215.
38. Oshima K, Ruhul Amin AR, Suzuki A, Hamaguchi M, Matsuda S. 2002. SHPS-I, a multifunctional transmembrane glycoprotein. FEBS Lett 519:1-7.
39. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM. 1998. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031.
40. Ravichandran KS. 2001. Signaling via Shc family adapter proteins. Oncogene 20:6322-6330.
41. Reaven P, Merat S, Casanada F, Sutphin M, Palinski W. 1997. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 17:2250-2256.
42. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH. 1995. Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol 147:1068-1080.
43. Riessen R, Kearney M, Lawler J, Isner JM. 1998. Immunolocalization of thrombospondin-I in human atherosclerotic and restenotic arteries. Am Heart J 135:357-364.
44. Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M. 2001. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-I-induced mitogenesis and glycogen synthesis. Endocrinology 142:5226-5235.
45. Schreyer SA, Wilson DL, LeBoeuf RC. 1998. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136:17-24.
46. Schwartz MA, Baron V. 1999. Interactions between mitogenic stimuli, or, a thousand and one connections. Curr Opin Cell Biol 11:197-202.
47. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ. 1991. Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 88:9402-9406.
48. Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgren Y, Ruoslahti E. 1984. Domain structure of vitronectin. Alignment of active sites. J Biol Chem 259:15307-15314.
49. Takada T, Matozaki T, Takeda H, Fukunaga K, Noguchi T, Fujioka Y, Okazaki I, Tsuda M, Yamao T, Ochi F, Kasuga M. 1998. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation. J Bio Chem 273:9234-9242.
50. Takagi J, Kamata T, Meredith J, Puzon-McLaughlin W, Takada Y. 1997. Changing ligand specificities of alphavbeta I and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J Biol Chem 272:19794-19800.
51. Thomas D, Bradshaw RA. 1997. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC 12 cells. Identification of a new Grb2.SosI binding site. J Biol Chem 272:22293-22299.
52. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. 1990. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82:27-36.
53. van der Geer P, Wiley S, Gish GD, Lai VK, Stephens R, White MF, Kaplan D, Pawson T. 1996. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc Natl Acad Sci USA 93:963-968.
54. Wight TN, Raugi GJ, Mumby SM, Bornstein P. 1985. Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 33:295-302.
55. Yamada KM, Even-Ram S. 2002. Integrin regulation of growth factor receptors. Nat Cell Biol 4:E75-E76.
56. Zheng B, Clemmons DR. 1998b. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:11217-11222.
57. Zheng B, Duan C, Clemmons DR. 1998a. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-likegrowth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem 273:8994-9000.
58. Zhu B, Zhao G, Witte DP, Hui DY, Fagin JA. 2001. Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142:3598-3606.